companydata.dkENDOGEN ApS: Financial statements 2015
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 18,574 and a net result of DKK -16,471 compared with DKK -36,822 the year before. That is a decrease of 0.3% compared with the year before. The profit margin was -88.7%. Equity amounted to DKK 56,122. The solvency ratio was 100%.
- Revenue
- 18,574 kr.
- Gross Profit
- -16,157 kr.
- Profit/Loss
- -16,471 kr.
- Equity
- 56,122 kr.
- Total Assets
- 56,122 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
ENDOGEN ApS has published its annual report for 2014. Revenue came to DKK 18,625, and the net result was DKK -36,822.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.